PGEN
Precigen Inc.
Company Overview
| Mkt Cap | $1.12B | Price | $4.15 |
| Volume | 4.18M | Change | +0.30% |
| P/E Ratio | -8.9 | Open | $4.13 |
| Revenue | $3.9M | Prev Close | $4.14 |
| Net Income | $-126.2M | 52W Range | $0.65 - $5.23 |
| Div Yield | N/A | Target | $8.25 |
| Overall | 52 | Value | 40 |
| Quality | 36 | Technical | 81 |
No chart data available
Stock Overview
Updated DailyPrecigen Inc. (PGEN) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $4.14 with a market capitalization of $1.12 billion. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows PGEN with a volume of 6.40 million shares. The stock opened down 0.25% from yesterday's close of $4.05. Current analyst estimates project earnings of $-0.28 per share for this year, with next year targeting $-0.04.
PGEN demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including MYMX, MRVI, NBIX, NSTG.
Key investment considerations for PGEN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 99.3%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PGEN | $4.15 | +0.3% | 4.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |